Yorktown Management & Research Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Yorktown Management & Research Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,300	Closed	-$229K	–	491
2015 Q2	$229K	Hold	1,300	–	–	0.04%	409
2015 Q1	$225K	Buy	+1,300	New	+$223K	0.04%	398
2014 Q4	–	Sell	-2,000	Closed	-$321K	–	457
2014 Q3	$321K	Hold	2,000	–	–	0.06%	142
2014 Q2	$294K	Hold	2,000	–	–	0.05%	213
2014 Q1	$277K	Hold	2,000	–	–	0.05%	238
2013 Q4	$253K	Buy	+2,000	New	+$207K	0.05%	288

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Yorktown Management & Research Company's JAZZ Position: Q3 2015 in Review

Yorktown Management & Research Company sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 1,300 shares — an estimated $229K sold.

Yorktown Management & Research Company first reported a position in JAZZ in Q4 2013 and held it in 6 quarters. The position peaked at $321K in Q3 2014. 361 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

Yorktown Management & Research Company reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Yorktown Management & Research Company sold 1,300 Jazz Pharmaceuticals shares in Q3 2015, an estimated $229K.
Yorktown Management & Research Company first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Yorktown Management & Research Company's Jazz Pharmaceuticals position peaked at $321K in Q3 2014.
361 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Yorktown Management & Research Company's 13F filing for Q3 2015, filed 5 Nov 2015.